Kukje Pharma: Controlling shareholder change

Change in control

An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).

Kukje Pharma shares rally on controlling shareholder change and retail buying.

Retail investors drive Kukje Pharma higher despite institutional and foreign selling, as the market weighs the implications of a shift in control.

• 10.06 ★★★★★ Controlling shareholder change shifts corporate governance
• 09.23 ★★ Files report on major shareholding